These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 4677063)

  • 21. [Selective tumour chemotherapy using oncobiograms (author's transl)].
    Volm M; Kaufmann M; Wayss K; Goerttler K; Mattern J
    Dtsch Med Wochenschr; 1974 Jan; 99(2):38-43. PubMed ID: 4129485
    [No Abstract]   [Full Text] [Related]  

  • 22. [Studies on the mechanism of cytostatic action of methylhydrazine, II].
    Weitzel G; Schneider F; Fretzdorff AM; Durst J; Hirschmann WD
    Hoppe Seylers Z Physiol Chem; 1967 Apr; 348(4):433-42. PubMed ID: 5587962
    [No Abstract]   [Full Text] [Related]  

  • 23. [Sensitivity testing of malignant human tumors against cytostatic agents. II].
    Mattern J; Kaufmann M; Volm M; Schütze U; Wayss K; Goerttler K; Tasca C
    Klin Wochenschr; 1972 Feb; 50(4):196-8. PubMed ID: 5011552
    [No Abstract]   [Full Text] [Related]  

  • 24. Chemotherapy of experimental meningeal carcinomatosis.
    Ushio Y; Posner JB; Shapiro WR
    Cancer Res; 1977 Apr; 37(4):1232-7. PubMed ID: 844048
    [No Abstract]   [Full Text] [Related]  

  • 25. [Cytostatic therapy of bronchial carcinoma].
    Dold U
    Dtsch Med Wochenschr; 1972 Apr; 97(15):618-9. PubMed ID: 4112729
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of the methionine antagonist L-2-amino-4-methoxy-trans-3-butenoic acid on the growth and metabolism of Walker carcinosarcoma in vitro.
    Tisdale MJ
    Biochem Pharmacol; 1980 Feb; 29(4):501-8. PubMed ID: 7370047
    [No Abstract]   [Full Text] [Related]  

  • 27. Studies of the mode of action of N-isopropyl-alpha-(2-methylhydrazino)-p-toluamide.
    Gale GR; Simpson JG; Smith AB
    Cancer Res; 1967 Jul; 27(7):1186-91. PubMed ID: 4952509
    [No Abstract]   [Full Text] [Related]  

  • 28. [Ineffectiveness of a drug combination on Yoshida sarcoma and Walker carcinosarcoma 256 of the rat and on Ehrlich carcinoma of the mouse].
    Zeller WJ; Wiessler M; Adzersen KH
    Arzneimittelforschung; 1972 Mar; 22(3):575-7. PubMed ID: 5067931
    [No Abstract]   [Full Text] [Related]  

  • 29. [Comparative studies of clinically equivalent doses of various cytostatic agents on the mouse Ehrlich ascites carcinoma and rat Walker carcinosarcoma 256 in vivo and in cell culture (in vitro)].
    Matthias M; Tanneberger S; Gummel H
    Arch Geschwulstforsch; 1970; 36(3):240-6. PubMed ID: 5498278
    [No Abstract]   [Full Text] [Related]  

  • 30. [Test of multi-step-therapy of cancer (combination of pretreatment with glucose with chemotherapy and whole body hyperthermia) in Walker- and DS-carcinosarcoma of rat (author's transl)].
    Heinrich M; Osswald H
    Arch Geschwulstforsch; 1974; 43(4):310-9. PubMed ID: 4429424
    [No Abstract]   [Full Text] [Related]  

  • 31. The sensitivity to chemotherapeutic agents of a rat tumour grown in immunosuppressed mice.
    Sheard CE; Double JA; Berenbaum MC
    Br J Cancer; 1971 Dec; 25(4):838-44. PubMed ID: 5144544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of guinea-pig serum on the Walker 256 carcinosarcoma.
    Dolowy WC; Schrek R; Henson D; Cornet J; Brown E
    Nature; 1968 Jun; 218(5146):1028-31. PubMed ID: 5656616
    [No Abstract]   [Full Text] [Related]  

  • 33. [Correlation of in vitro testing and therapeutical results in animal transplanted tumors after cytostatic treatment].
    Wayss K; Mattern J; Volm M
    Arzneimittelforschung; 1975 Jan; 25(1):77-81. PubMed ID: 50072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Ultrastructural changes in cells of the original tumors, metastases and stroma of rat walker-256 carcinosarcoma treated with a heparin complex with urea].
    Kolomina SM; Chentsov IuS; Pogodina LS; Kudriashov BA; Kalishevskaia TM
    Tsitol Genet; 1979; 13(1):8-15. PubMed ID: 442204
    [No Abstract]   [Full Text] [Related]  

  • 35. Relationship of uptake and binding of an antileukemic phthalanilide to its biochemical and chemotherapeutic effects on P388 lymphocytic leukemia cells.
    Yesair DW; Rogers WI; Baronowsky PE; Wodinsky I; Thayer PS; Kensler CJ
    Cancer Res; 1967 Feb; 27(2):314-21. PubMed ID: 6018563
    [No Abstract]   [Full Text] [Related]  

  • 36. [Chemotherapy of cancer. Hints for continuing medical education].
    Berndt H; Rieche K
    Z Arztl Fortbild (Jena); 1974 Feb; 68(4):193-5. PubMed ID: 4838434
    [No Abstract]   [Full Text] [Related]  

  • 37. [Inhibitory action of retinoic acid and N-(4-carboxyphenyl)-retinamide on the biosynthesis of DNA, RNA and protein in Ehrlich ascites carcinoma].
    Song ZP; Han R
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Dec; 6(6):418-20. PubMed ID: 6242543
    [No Abstract]   [Full Text] [Related]  

  • 38. Antitumor activity of cis-dihalogenobis(1-phenyl-1,3-butanedionato) titanium(IV) compounds against Walker 256 carcinosarcoma. A new class of antineoplastic agents.
    Keller HJ; Keppler B; Schmähl D
    Arzneimittelforschung; 1982; 32(8):806-7. PubMed ID: 6890355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative studies on the effectiveness of various cytostatics and radiation therapy of experimental tumors in a sample experiment with special regard to telegammatherapy with cobalt60. Survival experiments and cures after the administration of cyclophosphamide ester, triethyleneiminebenzoquinone and radiation separately and in various combinations with Yoshida sarcoma, carcinoma Walker and Jensen sarcoma in albino rats].
    Schneider R
    Strahlentherapie Sonderb; 1965; 61():367-72. PubMed ID: 5827135
    [No Abstract]   [Full Text] [Related]  

  • 40. [Kinetics of regression and relapse of Walker carcinosarcoma treated with alkylating agents].
    Parkanskiĭ MN; Konovalova NP; Emanuél' N
    Izv Akad Nauk SSSR Biol; 1973; (1):144-6. PubMed ID: 4218850
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.